Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - FENNEC PHARMACEUTICALS INC. | adhxf_10k.htm |
| EX-31.1 - CERTIFICATION - FENNEC PHARMACEUTICALS INC. | adhxf_ex311.htm |
| EX-31.2 - CERTIFICATION - FENNEC PHARMACEUTICALS INC. | adhxf_ex312.htm |
| EX-16 - PRESS RELEASE - FENNEC PHARMACEUTICALS INC. | adhxf_ex991.htm |
| EX-99.1 - AUDIT COMMITTEE CHARTER - FENNEC PHARMACEUTICALS INC. | adhxf_ex16.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Adherex Technologies Inc. (the “Company”) on Form
10-K for the period ended Decmeber 31, 2009 (the “Report”), each of the
undersigned, Rostislav Raykov, Chief Executive Officer of the Company, and
Robert Andrade, Chief Financial Officer of the Company, hereby certifies
pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Date: March
30, 2010
|
By:
|
/s/Rostivlav Raykov | |
| Rostislav Raykov | |||
| Chief Executive Officer |
|
Date: March
30, 2010
|
By:
|
/s/ Robert Andrade | |
| Robert Andrade | |||
| Chief Financial Officer |